HALISTER: Gilead Avoids Billions in U.S. Taxes on Its $1,000-a-Pill Drug

Gilead Avoids Billions in U.S. Taxes on Its $1,000-a-Pill Drug

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GILD US (Gilead Sciences Inc) ABBV US (AbbVie Inc)

People Cara Miller (Gilead Sciences Inc) Robert Willens (Robert Willens LLC) Robin Washington (Gilead Sciences Inc)

Topics Viral Hepatitis

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283